Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes...total of 540M thank you
That initial offering was old news. It's an extra 250 however you want to spin it. You were wrong, again. Move along
Thank you for making my point for me. It's 540M regardless of how you want to spin it.
And it's adding 250,000,000 not 540. 540 is the total after the amendment.
Your information on here is severely lacking.
Nothing like some pr to help. This will make it's way back up before approval
nothing like some dilution to destroy shareholders!
nothing has changed with the active submission track. i do a lot of med / pharma plays. asking for another test, or even re-submitting a test, is commonplace. asking for a test does not alter the submission track at all. its the FDA's job to be thorough.
if it were "denied" as some morons want us to believe, the FDA would not have asked for an additional test - they would have just closed the submission request and told them to re-apply again later. did anyone see that happen? no.
as for timeframe- the stupid crowd thinks this is going to be wrapped up in a few weeks. this process can take several months. the payday is worth the wait. unfortunately for some, the term "waiting" means 2 weeks tops... lmfao!
$RMSL The story has not changed here- all that changed is the MM washed out a lot of dumb people and their shares went to smarter hands.
It’s not that black and white. They need additional testing/ information. It’s neither approved nor denied. It’s in between submitted and approved/denied.
here's another fact, one cannot argue with a stupid person because they will drag you to their level then beat you with experience. heh
let the morons sell.
the opposite of smart is....
lol...NOT a fact in any way other than in the fantasy section of your mind.
you cannot make things up and try to pass it off as fact. hilarious.
$rmsl
Yes the condensation test which is a new requirement due to the Phillips recall.
You stated 510k denied which is not the case, this application is still ongoing and I expect will not take long to get test done and device approved pending result of test.
Denied Implies they have to start 510k process all over again with a new submission, that is not the case.
Yes - the 510K has not been withdrawn....but it won't be approved in current state because more testing is required.. The opposite of "approved" is..........
You are totally wrong, FDA filing is still on going, and on submission of additional test FDA will continue with current 510k application.
Denied in current state is a fact. Sorry you dont like that fact.
It has not been denied, it’s still in the que waiting for additional test to be run. Once test done and submitted 510k should not take long.
Sure- I thought the PR was crystal clear, IMO. Its not unusual to be asked for an additional test or a specific test revision during a 510k in process.
but we got morons peddling lies like the submission application was "denied", which is hilarious.
It's pretty sad that some folks resort to these low-moral tactics to try and get cheap shares at the expense of others.
GL - OTC is volatile especially in thinly traded stocks. always has been. patience.
LMAO...means NOTHING. there are stocks with mega-billions OS trading at much higher prices.
in OTC it's much better to have a billion OS than a million OS. shares are the fuel which powers OTC and creates large runs.
you'll have to do better than that son. you're not looking at the right things.
O/S about to go over 1 billion- up from 73M in 2019..theres some FUD for you.
510K has been denied in current state because the company is incompetent and didn't do required testing after YEARS of development. You can view it as FUD or however you want but the price drop reflects my statement. YEARS of development..go look at PRs from 2017, 2018, 2019. You'd think this was a scam.
"The company has been advised by the FDA after considerable correspondence that additional testing is required for its 510K submission. Remsleep is proceeding with the testing as soon as possible." - so much for 100% success rate with that company they hired
Thanks for the clarity, additional testing and hopefully approval.
$rmsl -definite overreaction- 510k in progress, they need to run an additional test. nothing has been "denied" like the FUD peddlers are reporting.
Could be a quick fix if it's only 1 item
If you use E*TRADE it’s under ….
News ….
Triple zero again or rebound?
I’m buying here at 12 for a trade as investment grade flew out the window from no FDA approval.
How long till the good doctor fixes it ??
Gambling on price here buying end of day !
This is a trading vehicle IMO
again. where is it denied? amended so does not say that at all.
where do you see it was denied?
I just saw that, would have liked a little more detail in the PR.
What makes no sense though is that amendment was still priced at 3 cents, who is going to buy shares at 3 cents, unless they have someone already lined up to buy these.
And now we know why. 510K denied - more testing needed...classic
"Proceeds from Reg A will be used for additional product development, expected new patent application(s), aggressive marketing, product inventory after 510K approval."
Uh..ya it is new and has to do with the 1-A that was filed on 6/2/21. The last 1-A was filed in 2019...two different offerings.
It’s nothing new, it’s been there for many years.
It's an offering - regardless if it's an amendment or not. And check my post history..been around this stock for awhile.
If you have held as long as I have you would have seen same filings many times before, certainly nothing new.
You must have chased back in April if you are down 60%
$RMSL -exactly...looks like some morons sold based on that...#dumbazzes
lol
Gave me the chance to add a few more cheapies. I believe FDA news imminent.
Just an amendment, that has been out for several years.
News out about 290MM offering @ .03. That raises $8.7MM not sure how this will play out. GLTA
https://ih.advfn.com/stock-market/USOTC/remsleep-pk-RMSL/stock-news/86384294/post-qualification-amendment-to-a-1-a-offering-sta
looks like no. I am down 61% on this. They wasted too much time before the pandemic and now they have little chance of recovering. Management might have blown it now that we are headed for an economic downturn.
Any links would be much appreciated!
Is it true they got a contract with The National Sleep Institute and federal government?
Followers
|
309
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |